Anaplastic Large Cell Lymphoma, ALK-negative
Showing 1 - 8 of 8
T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail
Recruiting
- T-cell Lymphoma
- +30 more
- Optional Blood Sample
- Optional Nail Sample
-
Duarte, California
- +25 more
Jul 28, 2023
Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States
Recruiting
- Adenoid Cystic Skin Carcinoma
- +38 more
- Biopsy
- +6 more
-
Los Angeles, California
- +35 more
Jan 31, 2023
Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial
Completed
- Anaplastic Large Cell Lymphoma, ALK-Negative
- +9 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, California
- +7 more
Nov 4, 2022
Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)
Completed
- Peripheral T Cell Lymphoma
- +18 more
-
Vancouver, British Columbia, Canada
- +29 more
Apr 29, 2022
T Lymphoblastic Leukemia/Lymphoma, Extramedullary NK-T-cell Lymphoma, Nasal Type, Peripheral T-cell Lymphoma, Nonspecific Trial
Recruiting
- T Lymphoblastic Leukemia/Lymphoma
- +6 more
- T cell injection targeting CD7 chimeric antigen receptor
-
Zhengzhou, Henan, ChinaFirst Affiliated Hospital of Zhengzhou University
Jan 4, 2021
Anaplastic Large Cell Lymphoma, ALK-Negative, Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in
Completed
- Anaplastic Large Cell Lymphoma, ALK-Negative
- +5 more
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Westwood, Kansas
- +2 more
Nov 7, 2019
Risk Stratification of Nodal PTCL
Completed
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- +2 more
-
Jeonju, Korea, Republic ofChonbuk Nationla University Hospital
Aug 5, 2019
Peripheral T Cell Lymphoma Unspecified, Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T Cell Lymphoma Trial
Completed
- Peripheral T Cell Lymphoma Unspecified
- +3 more
- RAD001 (Everolimus)
-
Goyang-si, Kyoungki-do, Korea, Republic of
- +4 more
Mar 1, 2015